Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 1202 citing articles:

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 7, pp. 585-594
Open Access | Times Cited: 2900
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
Nick Andrews, Julia Stowe, Freja Kirsebom, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 16, pp. 1532-1546
Open Access | Times Cited: 2091
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
Sara Y. Tartof, Jeff Slezak, Heidi Fischer, et al.
The Lancet (2021) Vol. 398, Iss. 10309, pp. 1407-1416
Open Access | Times Cited: 1166
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Shuo Feng, Daniel J. Phillips, Thomas White, et al.
Nature Medicine (2021) Vol. 27, Iss. 11, pp. 2032-2040
Open Access | Times Cited: 1104
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape
John S. Tregoning, Katie E. Flight, Sophie L. Higham, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 10, pp. 626-636
Open Access | Times Cited: 1031
SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
Aziz Sheikh, Jim McMenamin, J. R. Taylor, et al.
The Lancet (2021) Vol. 397, Iss. 10293, pp. 2461-2462
Open Access | Times Cited: 997
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
Stephen J. Thomas, Edson Duarte Moreira, Nicholas Kitchin, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 19, pp. 1761-1773
Open Access | Times Cited: 888
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
Victoria Hall, Sarah Foulkes, Ferdinando Insalata, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 13, pp. 1207-1220
Open Access | Times Cited: 621
Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19
Myron J. Levin, Andrew Ustianowski, Stéphane De Wit, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 23, pp. 2188-2200
Open Access | Times Cited: 614
Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis
Caifang Zheng, Weihao Shao, Xiaorui Chen, et al.
International Journal of Infectious Diseases (2021) Vol. 114, pp. 252-260
Open Access | Times Cited: 577
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study
Michela Antonelli, Rose Penfold, Jordi Merino, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 1, pp. 43-55
Open Access | Times Cited: 466
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings
Mark G. Thompson, Edward Stenehjem, Shaun J. Grannis, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 15, pp. 1355-1371
Open Access | Times Cited: 440
Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants
David W. Eyre, Donald Taylor, M. B. Purver, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 8, pp. 744-756
Open Access | Times Cited: 438
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1
Madhumita Shrotri, Annalan M D Navaratnam, Vincent Nguyen, et al.
The Lancet (2021) Vol. 398, Iss. 10298, pp. 385-387
Open Access | Times Cited: 402
mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar
Hiam Chemaitelly, Hadi M. Yassine, Fatiha M. Benslimane, et al.
Nature Medicine (2021) Vol. 27, Iss. 9, pp. 1614-1621
Closed Access | Times Cited: 394
Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)
Sean Wei Xiang Ong, Calvin J. Chiew, Li Wei Ang, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e1128-e1136
Open Access | Times Cited: 389
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
Ann R. Falsey, Magdalena E. Sobieszczyk, Ian Hirsch, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 25, pp. 2348-2360
Open Access | Times Cited: 381
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
Nick Andrews, Elise Tessier, Julia Stowe, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 4, pp. 340-350
Open Access | Times Cited: 379
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England
Nick Andrews, Julia Stowe, Freja Kirsebom, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 831-837
Open Access | Times Cited: 372
Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study
Daniel Ayoubkhani, Charlotte Bermingham, Koen B. Pouwels, et al.
BMJ (2022), pp. e069676-e069676
Open Access | Times Cited: 347
Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection
Martina Patone, Lahiru Handunnetthi, Defne Saatci, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2144-2153
Open Access | Times Cited: 331
Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
Emma Pritchard, Philippa C. Matthews, Nicole Stoesser, et al.
Nature Medicine (2021) Vol. 27, Iss. 8, pp. 1370-1378
Open Access | Times Cited: 317
Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study
Martina McMenamin, Joshua Nealon, Yun Lin, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 10, pp. 1435-1443
Open Access | Times Cited: 315
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Qiao Liu, Chenyuan Qin, Min Liu, et al.
Infectious Diseases of Poverty (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 311
Page 1 - Next Page

Scroll to top